Advanced Search

Journal of Traditional Chinese Medicine >

2023 , Vol. 43 >Issue 6: 1068 - 1071

DOI: https://doi.org/10.19852/j.cnki.jtcm.20230904.001

Meta-Analyses

Long-term effects of Qingfei Paidu decoction (清肺排毒汤) in patients with coronavirus disease 2019 acute pneumonia after treatment: a protocol for systematic review and Meta-analysis

  • Rong FAN ,
  • Haoyu HE ,
  • Tao TANG ,
  • Hanjin CUI
Expand
  • 1 Institute of Integrative Medicine, Xiangya Hospital, Central South University, Changsha 410008, China
    2 Department of Psychology, School of Educational Science, Hunan First Normal University, Key Laboratory of Hunan Province for Children's Psychological Development and Brain Cognitive Science, Changsha 410205, China

Received date: 2022-05-06

  Accepted date: 2022-08-01

  Online published: 2023-09-04

Fold

Abstract

This study aims to provide evidence regarding whether Qingufei paidu decoction (清肺排毒汤, QFPD) treatment in the acute phase shows long-term benefits for coronavirus disease 2019-associated sequelae. The 10 databases will be retrieved. Every reference list of related trials and gray literature will be searched as well. Study screening, data extraction, and risk of bias evaluation will be performed by two reviewers (CUI Hanjin and FAN Rong). Data analysis will be conducted by using STATA (version 14). Statistical heterogeneity will be explored by a standard χ2 test with a significance level of P < 0.10. Funnel plots, Egger’s & Begg’s test, and Trim and Fill analysis will be used for publication bias assessment. The results of the present Meta-analysis and systematic review will be disseminated via peer-review journal publication. Ethical approval is not required, as this Meta-analysis will not contain any individual patient data. This systematic review has been registered on PROSPERO (registration number: CRD42021246937) on 15 April 2021.

Key words： COVID-19; Qingfei paidu decoction; protocol; systematic review; Meta-analysis

Cite this article

Rong FAN , Haoyu HE , Tao TANG , Hanjin CUI . Long-term effects of Qingfei Paidu decoction (清肺排毒汤) in patients with coronavirus disease 2019 acute pneumonia after treatment: a protocol for systematic review and Meta-analysis[J]. Journal of Traditional Chinese Medicine, 2023 , 43(6) : 1068 -1071 . DOI: 10.19852/j.cnki.jtcm.20230904.001

References

1. Badakhsh M, Dastras M, Sarchahi Z, et al. Complementary and alternative medicine therapies and COVID-19: a systematic review. Rev Environ Health 2021; 36: 443-50.
2. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). JAMA 2020; 324: 782.
3. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new york city area. JAMA 2020; 323: 2052-59.
4. Zhong L, Lam WC, Yang W, et al. Potential targets for treatment of coronavirus disease 2019 (COVID-19): a review of Qing-Fei-Pai-Du-Tang and its major herbs. Am J Chin Med 2020; 48: 1051-71.
5. Zhang L, Zheng X, Bai X, et al. Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: a national retrospective registry study. Phytomedicine 2021; 85: 153531.
6. Chen J, Wang YK, Gao Y, et al. Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming. Biomed Pharmacother 2020; 129: 110281.
7. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and Meta-analysis. Sci Rep 2021; 11: 16144.
8. Huang C, Huang L, Wang Y, et al. 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397: 220-32.
9. Sterne J, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; 366: l4898.
10. Lo CK, Mertz D, Loeb M. Newcastle-Ottawa scale: comparing reviewers' to authors' assessments. Bmc Med Res Methodol 2014; 14: 45.
11. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative Meta-analysis. J Clin Epidemiol 2008; 61: 64-75.
12. Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many Meta-analyses. J Clin Epidemiol 2008; 61: 763-9.
13. Sun YN, Lü WL, Xiao Y, et al. Qingfei Paidu Decoction for treatment of mild/moderate COVID-19 in 295 cases: a multi-centered study. Zhong Yi Za Zhi 2021; 62: 599-603.
14. Shi N, Liu B, Liang N, et al. Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-19: a retrospective multicenter cohort study. Pharmacol Res 2020; 161: 105290.
15. Chen H, Qi S, Shen J. One-Compound-Multi-Target: combination prospect of natural compounds with thrombolytic therapy in acute ischemic stroke. Curr Neuropharmacol 2017; 15: 134-56.
16. Cui H, Liu T, Li P, et al. An intersectional study of LncRNAs and mRNAs reveals the potential therapeutic targets of buyang huanwu decoction in experimental intracerebral hemorrhage. Cell Physiol Biochem 2018; 46: 2173-86.
17. DU HZ, Hou XY, Miao YH, Huang BS, Liu DH. Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP). Zhong Guo Tian Ran Yao Xue 2020; 18: 206-10.
Options
Outlines

/

〈 〉